Dr. Bryan McComb (he/his/him) stands as a biostatistician at Pfizer, dedicating his expertise to the design and analysis of late-stage clinical trials within the non-malignant hematology group. Beyond his role at Pfizer, Dr. McComb is a versatile independent consultant and educator in mathematics and biostatistics with 10 years of background and knowledge. Driven by a fervent dedication to innovation, his current research interests are in the application of master protocol designs within the rare disease space. He received his B.S. in Mathematics from Muhlenberg college and his Ph.D. in Biostatistics from New York University, solidifying his expertise and passion for pushing scientific boundaries.